When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Supressão adrenal

Last reviewed: 26 Mar 2025
Last updated: 12 Apr 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • cessação súbita ou redução rápida de glicocorticoides
  • colapso circulatório agudo com hipotensão e taquicardia
Full details

Other diagnostic factors

  • lassidão e sintomas constitucionais generalizados
  • história de ganho de peso e aumento do apetite
  • história de depressão, agitação ou distúrbios do sono
  • características cushingoides ao exame
  • história de diabetes de difícil controle ou hipertensão
  • ausência de hiperpigmentação ou estigmas autoimunes
  • uso de medroxiprogesterona
  • história de tratamento endógeno para a síndrome de Cushing
Full details

Risk factors

  • administração sistêmica de glicocorticoide
  • alta potência ou dose de glicocorticoides exógenos
  • tratamento prolongado com glicocorticoide (por exemplo, >3 semanas)
  • administração local de glicocorticoide
  • uso de megestrol
  • programação não fisiológica da dose de glicocorticoide
  • uso de medroxiprogesterona
Full details

Diagnostic tests

1st tests to order

  • perfil bioquímico sérico abrangente
  • cortisol sérico matinal
  • cortisol salivar matinal
  • teste de estímulo com o hormônio adrenocorticotrópico (ACTH)
  • Hemograma completo
  • testes da função tireoidiana
Full details

Tests to consider

  • teste de tolerância à insulina (TTI)
  • teste da metirapona noturna
  • glicocorticoides sintéticos urinários
Full details

Treatment algorithm

INITIAL

características da crise adrenal

ACUTE

estresse intercorrente leve

estresse intercorrente intenso

ONGOING

pacientes estáveis que estão tomando corticosteroides para doença subjacente: elegíveis para descontinuação ou esquema de retirada gradual

Contributors

Authors

Suzanne L. Quinn Martinez, MD
Suzanne L. Quinn Martinez

Staff Endocrinologist

Orlando Veterans Administration Hospital

Associate Professor Internal Medicine

University of Central Florida

Orlando

FL

Disclosures

SLQM declares that she has no competing interests.

Acknowledgements

Dr Suzanne L. Quinn Martinez would like to gratefully acknowledge Dr M. Cecilia Lansang, a previous contributor to this topic.

Disclosures

MCL is a consultant for the Sanofi group of companies and is an author of several references cited in this topic.

Peer reviewers

Diane Mary Donegan, MB BCh BAO, MRCPI, Ms

Assistant Professor of Medicine

Indiana University

Indianapolis

MI

Disclosures

DMD is a member of a paid advisory board for Recordati and Corcept. DMD is also a site investigator for Corcept and Chiasma.

Antoine Tabarin, MD

Head

Department of Endocrinology

University Hospital of Bordeaux

Pessac

France

Disclosures

AT declares that he has no competing interests.

Maralyn Druce, MA, MBBS, MRCP, PhD

Clinical Lecturer

Honorary Consultant

Department of Endocrinology

Barts and The London School of Medicine and Dentistry

St Bartholomew's Hospital

London

UK

Disclosures

MD declares that she has no competing interests.

  • Differentials

    • Insuficiência adrenal primária
    • Compressão da hipófise, tumor, trauma cranioencefálico e cirurgia (não Cushing)
    • Síndrome de abstinência de corticosteroides
    More Differentials
  • Guidelines

    • Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity
    • Adrenal insufficiency and adrenal crisis-who is at risk and how should they be managed safely
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer